Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$13.53 - $23.34 $334,245 - $576,591
-24,704 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$16.14 - $22.6 $59,718 - $83,620
3,700 Added 17.62%
24,704 $558,000
Q4 2021

Feb 14, 2022

SELL
$18.64 - $36.77 $54,894 - $108,287
-2,945 Reduced 12.3%
21,004 $394,000
Q3 2021

Nov 15, 2021

BUY
$32.83 - $43.0 $786,245 - $1.03 Million
23,949 New
23,949 $787,000
Q2 2021

Aug 16, 2021

SELL
$34.41 - $44.03 $288,046 - $368,575
-8,371 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$37.29 - $47.19 $617,149 - $780,994
-16,550 Reduced 66.41%
8,371 $321,000
Q4 2020

Feb 16, 2021

BUY
$34.3 - $44.09 $854,790 - $1.1 Million
24,921 New
24,921 $1.09 Million
Q1 2020

May 15, 2020

SELL
$30.0 - $54.18 $2.71 Million - $4.89 Million
-90,321 Closed
0 $0
Q4 2019

Feb 18, 2020

SELL
$42.29 - $52.2 $612,443 - $755,960
-14,482 Reduced 13.82%
90,321 $4.39 Million
Q3 2019

Nov 14, 2019

SELL
$42.06 - $51.64 $1.94 Million - $2.38 Million
-46,087 Reduced 30.54%
104,803 $4.98 Million
Q2 2019

Aug 14, 2019

SELL
$33.93 - $43.66 $1.24 Million - $1.6 Million
-36,649 Reduced 19.54%
150,890 $6.48 Million
Q1 2019

May 15, 2019

BUY
$26.74 - $41.32 $117,228 - $181,146
4,384 Added 2.39%
187,539 $7.25 Million
Q4 2018

Feb 14, 2019

SELL
$25.26 - $38.43 $660,523 - $1 Million
-26,149 Reduced 12.49%
183,155 $5.22 Million
Q3 2018

Nov 14, 2018

BUY
$33.27 - $39.25 $2.17 Million - $2.55 Million
65,078 Added 45.12%
209,304 $8.19 Million
Q2 2018

Aug 14, 2018

SELL
$21.73 - $33.15 $409,480 - $624,678
-18,844 Reduced 11.56%
144,226 $4.67 Million
Q1 2018

May 15, 2018

BUY
$21.05 - $26.6 $3.43 Million - $4.34 Million
163,070 New
163,070 $3.58 Million

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.